ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 77 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,885,000 | +1150.9% | 870,000 | +1540.2% | 0.28% | +762.5% |
| Q2 2020 | $1,110,000 | -95.3% | 53,043 | -96.8% | 0.03% | -95.7% |
| Q1 2020 | $23,399,000 | -52.5% | 1,677,367 | -22.5% | 0.74% | -52.7% |
| Q4 2019 | $49,263,000 | +138.4% | 2,164,471 | +22.0% | 1.57% | +86.5% |
| Q3 2019 | $20,666,000 | +21.2% | 1,773,938 | +56.0% | 0.84% | +37.5% |
| Q2 2019 | $17,057,000 | +247.3% | 1,137,142 | +306.1% | 0.61% | +226.1% |
| Q1 2019 | $4,911,000 | +18.3% | 280,000 | 0.0% | 0.19% | +13.3% |
| Q4 2018 | $4,150,000 | -39.8% | 280,000 | 0.0% | 0.17% | -32.8% |
| Q3 2018 | $6,894,000 | +25.4% | 280,000 | 0.0% | 0.25% | +28.0% |
| Q2 2018 | $5,496,000 | -26.7% | 280,000 | -30.0% | 0.19% | -25.8% |
| Q1 2018 | $7,500,000 | – | 400,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |